AbbVie Inc. Files 8-K on Financial Operations

Ticker: ABBV · Form: 8-K · Filed: 2025-04-03T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, debt, operations

Related Tickers: ABBV

TL;DR

AbbVie dropped an 8-K on April 3rd detailing its financials and debt notes.

AI Summary

On April 3, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior notes, such as the Sec0.750 Senior Notes Due 2027 and Sec2.125 Senior Notes due 2028, indicating ongoing financial activities and debt management.

Why It Matters

This filing provides insight into AbbVie's current financial standing and debt structure, which is crucial for investors assessing the company's stability and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for AbbVie Inc.?

The primary purpose of this 8-K filing is to report on AbbVie Inc.'s results of operations and financial condition.

On what date was the earliest event reported in this filing?

The earliest event reported in this filing was on April 3, 2025.

What specific types of financial instruments are mentioned in relation to AbbVie Inc.'s filing?

The filing mentions various senior notes, including Sec0.750 Senior Notes Due 2027, Sec2.125 Senior Notes due 2028, Sec2625 Senior Notes Due 2028, Sec2125 Senior Notes Due 2029, and Sec1.250 Senior Notes due 2031.

In which state was AbbVie Inc. incorporated?

AbbVie Inc. was incorporated in Delaware.

What is AbbVie Inc.'s business address?

AbbVie Inc.'s business address is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL 60064.

From the Filing

0001551152-25-000023.txt : 20250403 0001551152-25-000023.hdr.sgml : 20250403 20250403161307 ACCESSION NUMBER: 0001551152-25-000023 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250403 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250403 DATE AS OF CHANGE: 20250403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 25809591 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 8-K 1 abbv-20250403.htm 8-K abbv-20250403 0001551152 false 0001551152 2025-04-03 2025-04-03 0001551152 exch:XCHI us-gaap:CommonStockMember 2025-04-03 2025-04-03 0001551152 exch:XNYS us-gaap:CommonStockMember 2025-04-03 2025-04-03 0001551152 exch:XNYS abbv:Sec0.750SeniorNotesDue2027Member 2025-04-03 2025-04-03 0001551152 exch:XNYS abbv:Sec2.125SeniorNotesdue2028Member 2025-04-03 2025-04-03 0001551152 exch:XNYS abbv:Sec2625SeniorNotesDue2028Member 2025-04-03 2025-04-03 0001551152 exch:XNYS abbv:Sec2125SeniorNotesDue2029Member 2025-04-03 2025-04-03 0001551152 exch:XNYS abbv:Sec1.250SeniorNotesdue2031Member 2025-04-03 2025-04-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  _____________________________________________________ FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): April 3, 2025   ABBVIE INC. (Exact name of registrant as specified in its charter) Delaware   001-35565   32-0375147 (State or other Jurisdiction   (Commission File Number)   (IRS Employer of Incorporation)       Identification No.)  _____________________________________________________ 1 North Waukegan Road North Chicago ,  Illinois 60064-6400 (Address of principal executive offices)(Zip Code)   Registrant’s telephone number, including area code:  ( 847 ) 932-7900   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐                       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐                       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐                       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐                       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.01 Par Value   ABBV   New York Stock Exchange Chicago Stock Exchange 0.750% Senior Notes due 2027 ABBV27 New York Stock Exchange 2.125% Senior Notes due 2028 ABBV28 New York Stock Exchange 2.625% Senior Notes due

View on Read The Filing